These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29301071)

  • 1. Attenuation of West Nile Virus NS2B/NS3 Protease by Amino Terminal Copper and Nickel Binding (ATCUN) Peptides.
    Pinkham AM; Yu Z; Cowan JA
    J Med Chem; 2018 Feb; 61(3):980-988. PubMed ID: 29301071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
    Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
    Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.
    Tomlinson SM; Watowich SJ
    Biochemistry; 2008 Nov; 47(45):11763-70. PubMed ID: 18855422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H; Singh NJ; Kim KS
    Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
    Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
    FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
    Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y; Samanta S; Cui T; Lam Y
    ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
    Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
    J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.
    de Oliveira AS; Gazolla PAR; Oliveira AFCDS; Pereira WL; de S Viol LC; Maia AFDS; Santos EG; da Silva ÍEP; Mendes TAO; da Silva AM; Dias RS; da Silva CC; Polêto MD; Teixeira RR; de Paula SO
    PLoS One; 2019; 14(9):e0223017. PubMed ID: 31557229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.
    Shiryaev SA; Kozlov IA; Ratnikov BI; Smith JW; Lebl M; Strongin AY
    Biochem J; 2007 Feb; 401(3):743-52. PubMed ID: 17067286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zirconium catalyzed synthesis of 2-arylidene Indan-1,3-diones and evaluation of their inhibitory activity against NS2B-NS3 WNV protease.
    Oliveira AFCDS; de Souza APM; de Oliveira AS; da Silva ML; de Oliveira FM; Santos EG; da Silva ÍEP; Ferreira RS; Villela FS; Martins FT; Leal DHS; Vaz BG; Teixeira RR; de Paula SO
    Eur J Med Chem; 2018 Apr; 149():98-109. PubMed ID: 29499491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of sortase A mediated by metal ATCUN complexes.
    Fidai I; Hocharoen L; Bradford S; Wachnowsky C; Cowan JA
    J Biol Inorg Chem; 2014 Dec; 19(8):1327-39. PubMed ID: 25217034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Protein Expr Purif; 2007 May; 53(1):87-96. PubMed ID: 17174105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of molecular interactions between Zika virus protease and peptides derived from the C-terminus of NS2B.
    Li Y; Loh YR; Hung AW; Kang C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):691-696. PubMed ID: 29908184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
    Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
    Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.
    Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD
    J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
    Huang D
    Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.